tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Bryan Brokmeier, 28 are a BUY (93.33%), 2 are a HOLD (6.67%).
Analyst Bryan Brokmeier, currently employed carries an average stock price target met ratio of 76.04% that have a potential upside of 70.7% achieved within 536 days. Previously, Bryan Brokmeier worked at CANTOR FITZGERALD.
Bryan Brokmeier’s has documented 62 price targets and ratings displayed on 8 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on TTOO, T2 Biosystms at 03-May-2017.
Analyst best performing recommendations are on PACB (PACIFIC BIOSCIENCES OF CALIFORNIA).
The best stock recommendation documented was for TTOO (T2 BIOSYSTMS) at 5/3/2017. The price target of $30000 was fulfilled within 133 days with a profit of $10150 (51.13%) receiving and performance score of 3.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$2.5
$0.54 (27.55%)
$2
1 months 7 days ago
(11-Nov-2024)
7/8 (87.5%)
$0.15 (6.38%)
134
Buy
$6
$4.04 (206.12%)
$7
1 months 7 days ago
(11-Nov-2024)
2/6 (33.33%)
$3.65 (155.32%)
26
Buy
$2
$0.04 (2.04%)
$12
1 months 7 days ago
(11-Nov-2024)
2/5 (40%)
$-0.35 (-14.89%)
56
Hold
$2
$0.04 (2.04%)
$4
4 months 6 days ago
(12-Aug-2024)
4/6 (66.67%)
$0.57 (39.86%)
125
Buy
$3
$1.04 (53.06%)
$15
4 months 10 days ago
(08-Aug-2024)
5/10 (50%)
$1.33 (79.64%)
123
What Year was the first public recommendation made by Bryan Brokmeier?
